Evaluation of malignancy using Ki-67, p53, EGFR and COX-2 expressions in gastrointestinal stromal tumors

doi:10.3748/wjg.v18.i20.2569

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 20

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4111)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-3) series.

Item

Count

PDF

359

HTML

3324

Figures (1-2)

233

Tables (1-3)

195

Sum=4111

May 28, 2012 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (23)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. May 28, 2012; 18(20): 2569-2575
Published online May 28, 2012. doi: 10.3748/wjg.v18.i20.2569

Full Size Figure Download Figure

Figure 2 Kaplan-Meier plots for predicting disease specific survival based on the modified National Institutes of Health consensus system (A), Ki-67 expression (B) and adjuvant imatinib therapy (C).

Citation: Jiang J, Jin MS, Suo J, Wang YP, He L, Cao XY. Evaluation of malignancy using Ki-67, p53, EGFR and COX-2 expressions in gastrointestinal stromal tumors. World J Gastroenterol 2012; 18(20): 2569-2575
URL: https://www.wjgnet.com/1007-9327/full/v18/i20/2569.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i20.2569